Market Overview:
Benzphetamine is a stimulant drug that is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. It belongs to the group of drugs called sympathomimetics, which are similar to the natural substances epinephrine and norepinephrine that are produced by the body. Benzphetamine works by increasing the amount of these substances in the brain.
Product Definition:
Benzphetamine is a stimulant drug that is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing the amount of dopamine in the brain.
25mg:
25mg is a small dose and can be split into two doses for the duration of an average single session. It has been used as a recreational drug, but with the advent of more potent drugs such as Adderall it has become more of a study drug. 25mg is also used in combination with other drugs to increase its potency, which I will get into later on in this article.
It's half life is around 6-8 hours.
50mg:
50mg is a typical dose for the Benzphetamine market. It can be used as an off-label drug for weight loss, narcolepsy, and attention deficit hyperactivity disorder (ADHD). The FDA has not approved it as a prescription drug yet; however, it is widely available over-the-counter.
It's main ingredient is dextroamphetamine; which is also known as amphetamine.
Application Insights:
The drug store application segment led the market and accounted for more than 54% share of the global revenue in 2017. Benzphetamine is widely used as a weight loss agent and to improve alertness, energy, and concentration in patients suffering from narcolepsy. The rising prevalence of obesity has created demand for diet pills which is expected to drive market growth over the forecast period.
The hospital application segment was valued at USDolll7 million in 2017 owing to its usage as an alternative therapy for depression along with other antidepressants such as SSRIs (selective serotonin reuptake inhibitors). Benzphetamine also possesses neuroprotective properties which aids its use as a treatment option for Parkinson¢â‚¬â„¢s disease. These factors are anticipated to increase product demand during the forecast period thereby driving hospitalization based applications thus leading benzphetamine market growth over next eight years or so.
Regional Analysis:
Asia Pacific dominated the global benzphetamine market in 2017 and is expected to continue its dominance over the forecast period. The region accounted for a share of more than 60% in terms of volume owing to high demand from countries such as China, India, Japan, and South Korea. Increasing use among patients suffering from obesity and attention-deficit/hyperactivity disorder (ADHD) is also expected to drive growth over the forecast period. In addition, growing penetration of generic brands such as Ritalin coupled with increasing awareness regarding treatment options will further propel market growth during the forecast period.
The Asia Pacific was followed by North America which accounted for a share of more than 20% in terms of revenue owing to rising product consumption among students studying in U.S., Canada, and Mexico along with adults seeking improved concentration or focus ability at work place or school time table etcetera).
Growth Factors:
- Increasing prevalence of obesity and weight-related disorders: The increasing prevalence of obesity and weight-related disorders is a major growth driver for the benzphetamine market. According to the World Health Organization, more than 1.9 billion adults were overweight in 2016, and 650 million were obese. This number is expected to increase to 2.2 billion by 2030. The growing awareness about the health risks associated with obesity is driving people to seek treatment for weight loss, which is fueling the demand for benzphetamine products.
- Rising incidence of ADHD: Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders in children and adolescents worldwide, affecting about 5%–7% of school-age children globally according to WHO estimates .The rising incidence of ADHD is another key growth driver for the benzphetamine market as these drugs are commonly prescribed for its treatment .
Scope Of The Report
Report Attributes
Report Details
Report Title
Benzphetamine Market Research Report
By Type
25mg, 50mg
By Application
Hospital, Drug Store
By Companies
Corepharma, Impax laboratories, Perrigo, Mallinckrodt, Pfizer, Boca Pharmacal, Nivagen Pharmaceuticals, Tedor Pharma, Pd Rx Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Benzphetamine Market Report Segments:
The global Benzphetamine market is segmented on the basis of:
Types
25mg, 50mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Corepharma
- Impax laboratories
- Perrigo
- Mallinckrodt
- Pfizer
- Boca Pharmacal
- Nivagen Pharmaceuticals
- Tedor Pharma
- Pd Rx Pharmaceuticals
Highlights of The Benzphetamine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 25mg
- 50mg
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Benzphetamine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Benzphetamine is a stimulant drug that is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing the levels of dopamine in the brain.
Some of the key players operating in the benzphetamine market are Corepharma, Impax laboratories, Perrigo, Mallinckrodt, Pfizer, Boca Pharmacal, Nivagen Pharmaceuticals, Tedor Pharma, Pd Rx Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Benzphetamine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Benzphetamine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Benzphetamine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Benzphetamine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Benzphetamine Market Size & Forecast, 2018-2028
4.5.1 Benzphetamine Market Size and Y-o-Y Growth
4.5.2 Benzphetamine Market Absolute $ Opportunity
Chapter 5 Global Benzphetamine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Benzphetamine Market Size Forecast by Type
5.2.1 25mg
5.2.2 50mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Benzphetamine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Benzphetamine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Benzphetamine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Benzphetamine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Benzphetamine Analysis and Forecast
9.1 Introduction
9.2 North America Benzphetamine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Benzphetamine Market Size Forecast by Type
9.6.1 25mg
9.6.2 50mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Benzphetamine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Benzphetamine Analysis and Forecast
10.1 Introduction
10.2 Europe Benzphetamine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Benzphetamine Market Size Forecast by Type
10.6.1 25mg
10.6.2 50mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Benzphetamine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Benzphetamine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Benzphetamine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Benzphetamine Market Size Forecast by Type
11.6.1 25mg
11.6.2 50mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Benzphetamine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Benzphetamine Analysis and Forecast
12.1 Introduction
12.2 Latin America Benzphetamine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Benzphetamine Market Size Forecast by Type
12.6.1 25mg
12.6.2 50mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Benzphetamine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Benzphetamine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Benzphetamine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Benzphetamine Market Size Forecast by Type
13.6.1 25mg
13.6.2 50mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Benzphetamine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Benzphetamine Market: Competitive Dashboard
14.2 Global Benzphetamine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Corepharma
14.3.2 Impax laboratories
14.3.3 Perrigo
14.3.4 Mallinckrodt
14.3.5 Pfizer
14.3.6 Boca Pharmacal
14.3.7 Nivagen Pharmaceuticals
14.3.8 Tedor Pharma
14.3.9 Pd Rx Pharmaceuticals
